Loading...
Please wait, while we are loading the content...
Polyarthritis and Psoriasiform Skin Lesions following Pembrolizumab Therapy.
| Content Provider | Europe PMC |
|---|---|
| Author | Koulouri, Vasiliki Karamouzis, Michalis V. Mavragani, Clio P. |
| Copyright Year | 2021 |
| Abstract | A notable feature of immune checkpoint inhibitor (ICI) therapy in oncology patients is its association with increased frequency of immune related adverse reactions, directly associated with their unique mechanism of action. These adverse events are of great interest to rheumatologists, as not only do they commonly require immunosuppressive therapeutic intervention, but can also aid in unveiling important immunopathogenetic pathways that underlie autoimmune phenomena. Herein we describe a case of psoriasiform skin lesions and polyarthritis in a patient receiving ICI for lung cancer. |
| Related Links | https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC8802194&blobtype=pdf |
| Journal | Mediterranean Journal of Rheumatology [Mediterr J Rheumatol] |
| Volume Number | 32 |
| DOI | 10.31138/mjr.32.4.367 |
| PubMed Central reference number | PMC8802194 |
| Issue Number | 4 |
| PubMed reference number | 35128331 |
| e-ISSN | 2529198X |
| Language | English |
| Publisher | The Mediterranean Journal of Rheumatology (MJR) |
| Publisher Date | 2021-12-27 |
| Access Restriction | Open |
| Rights License | This work is licensed under and Creative Commons Attribution-NonCommercial 4.0 International License. © 2021 The Mediterranean Journal of Rheumatology (MJR) |
| Subject Keyword | Immune checkpoint inhibitors skin lesions arthritis |
| Content Type | Text |
| Resource Type | Article |
| Subject | Rheumatology |